Literature DB >> 8141383

Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel.

D M Van Winkle1, G L Chien, R A Wolff, B E Soifer, K Kuzume, R F Davis.   

Abstract

Adenosine agonists and openers of the ATP-sensitive potassium (KATP) channel have been reported to limit infarct size (IS). We tested the hypothesis that these phenomena are interdependent. Anesthetized swine underwent 60 min of coronary artery occlusion and 90 min of reperfusion. Preconditioning was elicited by two cycles comprising 10 min of occlusion and 10 min of reperfusion (n = 7 swine). An intracoronary infusion of adenosine (Ado; n = 10) or (-)-N6-(2-phenylisopropyl)-adenosine (R-PIA; n = 7) replaced preconditioning ischemia. KATP channels were blocked with sodium 5-hydroxydecanoate (5-HD) in the absence (n = 6) or presence (n = 8) of R-PIA. Control pigs (n = 7) received saline vehicle. IS was assessed with tetrazolium and normalized as percentage of area at risk. Preconditioning resulted in a reduced IS compared with Control (3.9 +/- 1.8 vs. 43.5 +/- 6.9%, respectively; P < 0.0005). Ado and R-PIA also reduced IS [21.1 +/- 6.8 (P < 0.01) and 11.2 +/- 7.4% (P < 0.005), respectively]. 5-HD alone did not alter IS, but it abolished R-PIA-induced cardioprotection (IS 5-HD + R-PIA = 48.6 +/- 13.2%). Thus Ado A1-receptor agonists mimicked the cardioprotection of ischemic preconditioning. The Ado-induced limitation of IS was abolished by blockade of the KATP channel. We conclude that both Ado A1 receptors and KATP channels may be involved in ischemic preconditioning.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8141383     DOI: 10.1152/ajpheart.1994.266.2.H829

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  27 in total

Review 1.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 2.  Cardioprotective signaling to mitochondria.

Authors:  Keith D Garlid; Alexandre D T Costa; Casey L Quinlan; Sandrine V Pierre; Pierre Dos Santos
Journal:  J Mol Cell Cardiol       Date:  2008-12-11       Impact factor: 5.000

3.  Contribution of adenosine A(2A) and A(2B) receptors to ischemic coronary dilation: role of K(V) and K(ATP) channels.

Authors:  Zachary C Berwick; Gregory A Payne; Brandon Lynch; Gregory M Dick; Michael Sturek; Johnathan D Tune
Journal:  Microcirculation       Date:  2010-11       Impact factor: 2.628

Review 4.  Salvage of jeopardized myocardium by ischemic preconditioning: is the quest over?

Authors:  R Strasser; P Htun; W Schaper
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

Review 5.  Limitation of infarct size by myocardial ischemic preconditioning.

Authors:  D M Van Winkle
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

6.  Chemical preconditioning: a cytoprotective strategy.

Authors:  M W Riepe; A C Ludolph
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

7.  Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning.

Authors:  A M Vogt; P Htun; M Arras; T Podzuweit; W Schaper
Journal:  Basic Res Cardiol       Date:  1996 Sep-Oct       Impact factor: 17.165

8.  Ischemic and pharmacological preconditioning induces further delayed protection in transgenic mouse cardiac myocytes over-expressing adenosine A1 receptors (A1AR): role of A1AR, iNOS and K(ATP) channels.

Authors:  Mohammed A Nayeem; G Paul Matherne; S Jamal Mustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-25       Impact factor: 3.000

9.  Involvement of ATP-sensitive potassium channels in preconditioning protection.

Authors:  S Rohmann; H Weygandt; P Schelling; L Kie Soei; P D Verdouw; I Lues
Journal:  Basic Res Cardiol       Date:  1994 Nov-Dec       Impact factor: 17.165

Review 10.  Impact of hypoglycemic agents on myocardial ischemic preconditioning.

Authors:  Rosa Maria Rahmi Garcia; Paulo Cury Rezende; Whady Hueb
Journal:  World J Diabetes       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.